• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Time is on our side - rethinking the concept of time to treatment for prostate cancer.

作者信息

Palmer Nynikka R, Carroll Peter R, Washington Samuel L

机构信息

Division of General Internal Medicine, Zuckerberg San Francisco General Hospital, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.

Department of Urology, University of California San Francisco, San Francisco, CA, USA.

出版信息

Nat Rev Urol. 2025 May;22(5):251-252. doi: 10.1038/s41585-024-00977-6.

DOI:10.1038/s41585-024-00977-6
PMID:39613985
Abstract
摘要

相似文献

1
Time is on our side - rethinking the concept of time to treatment for prostate cancer.时间站在我们这边——重新思考前列腺癌治疗时间的概念。
Nat Rev Urol. 2025 May;22(5):251-252. doi: 10.1038/s41585-024-00977-6.
2
Rethinking active surveillance for prostate cancer in African American men.重新思考非裔美国男性前列腺癌的主动监测。
Transl Androl Urol. 2018 Sep;7(Suppl 4):S397-S410. doi: 10.21037/tau.2018.06.19.
3
Let's rethinking about the safety of phosphodiesterase type 5 inhibitor in the patients with erectile dysfunction after radical prostatectomy.让我们重新思考5型磷酸二酯酶抑制剂在前列腺癌根治术后勃起功能障碍患者中的安全性。
J Exerc Rehabil. 2016 Jun 30;12(3):143-7. doi: 10.12965/jer.1632646.323. eCollection 2016 Jun.
4
Rethinking prostate cancer screening: could MRI be an alternative screening test?重新思考前列腺癌筛查：磁共振成像（MRI）可否作为替代筛查试验？
Nat Rev Urol. 2020 Sep;17(9):526-539. doi: 10.1038/s41585-020-0356-2. Epub 2020 Jul 21.
5
Side-effects of treatment for localized prostate cancer: are they valued differently by patients and healthy controls?局限性前列腺癌治疗的副作用：患者和健康对照对其的重视程度是否不同？
BJU Int. 2007 Apr;99(4):801-6. doi: 10.1111/j.1464-410X.2006.06707.x. Epub 2007 Jan 16.
6
Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy.局部晚期前列腺癌的淋巴结疾病图谱：基于血管而非骨骼解剖结构重新思考盆腔淋巴结照射的临床靶区
Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1262-9. doi: 10.1016/j.ijrobp.2005.07.952.
7
Words of wisdom. Re: Rethinking screening for breast cancer and prostate cancer.至理名言。关于：重新思考乳腺癌和前列腺癌的筛查
Eur Urol. 2010 Mar;57(3):540. doi: 10.1016/j.eururo.2009.12.014.
8
Rethinking cancer survivorship: the Prostate Cancer Survivorship Essentials Framework.重新思考癌症幸存者问题：前列腺癌幸存者基本要素框架
Med J Aust. 2021 Jul;215(2):94-94.e1. doi: 10.5694/mja2.51142. Epub 2021 Jun 15.
9
Beyond the Horizon: Rethinking Prostate Cancer Treatment Through Innovation and Alternative Strategies.超越地平线：通过创新与替代策略重新思考前列腺癌治疗
Cancers (Basel). 2024 Dec 29;17(1):75. doi: 10.3390/cancers17010075.
10
Use of Persuasive Language in Communication of Risk during Prostate Cancer Treatment Consultations.在前列腺癌治疗咨询中使用有说服力的语言来传达风险。
Med Decis Making. 2024 Apr;44(3):320-334. doi: 10.1177/0272989X241228612. Epub 2024 Feb 12.

本文引用的文献

1
Delayed definitive management of localized prostate cancer: what do we know?局限性前列腺癌的延迟确定性治疗：我们了解什么？
Prostate Cancer Prostatic Dis. 2025 Jun;28(2):280-287. doi: 10.1038/s41391-024-00876-2. Epub 2024 Aug 11.
2
Evaluation of blood and urine based biomarkers for detection of clinically-significant prostate cancer.评估基于血液和尿液的生物标志物用于检测具有临床意义的前列腺癌。
Prostate Cancer Prostatic Dis. 2025 Mar;28(1):45-55. doi: 10.1038/s41391-024-00840-0. Epub 2024 Jun 10.
3
Decision Regret in Patients with Localised Prostate Cancer: A Systematic Review and Meta-analysis.
局部前列腺癌患者的决策后悔：系统评价和荟萃分析。
Eur Urol Oncol. 2023 Oct;6(5):456-466. doi: 10.1016/j.euo.2023.02.005. Epub 2023 Mar 3.
4
Decisional Regret Among Men With Prostate Cancer: What Is Involved?前列腺癌男性患者的决策性遗憾：涉及哪些方面？
JAMA Oncol. 2022 Jan 1;8(1):59-60. doi: 10.1001/jamaoncol.2021.5137.
5
Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review.中高危前列腺癌患者延迟根治性前列腺切除术的肿瘤学影响：系统评价。
World J Urol. 2021 Nov;39(11):4085-4099. doi: 10.1007/s00345-021-03703-8. Epub 2021 May 28.
6
Systematic Review of Time to Definitive Treatment for Intermediate Risk and High Risk Prostate Cancer: Are Delays Associated with Worse Outcomes?系统评价：中危和高危前列腺癌的确定性治疗时间：延迟是否与预后更差相关？
J Urol. 2021 May;205(5):1263-1274. doi: 10.1097/JU.0000000000001601. Epub 2021 Jan 14.
7
Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common Cancers.评估常见癌症患者队列的治疗开始时间和生存情况。
JAMA Netw Open. 2020 Dec 1;3(12):e2030072. doi: 10.1001/jamanetworkopen.2020.30072.
8
Mortality due to cancer treatment delay: systematic review and meta-analysis.癌症治疗延迟导致的死亡率：系统评价与荟萃分析
BMJ. 2020 Nov 4;371:m4087. doi: 10.1136/bmj.m4087.
9
Shared decision-making for prostate cancer screening and treatment: a systematic review of randomised controlled trials.前列腺癌筛查与治疗的共同决策：随机对照试验的系统评价
Swiss Med Wkly. 2018 Feb 23;148:w14584. doi: 10.4414/smw.2018.14584. eCollection 2018.
10
Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review.有症状癌症的诊断和治疗时间增加是否与较差的预后相关？系统评价。
Br J Cancer. 2015 Mar 31;112 Suppl 1(Suppl 1):S92-107. doi: 10.1038/bjc.2015.48.